Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Human Gastrointestinal Physiology Data: early-phase trial registry

1 of 1 indexed Human Gastrointestinal Physiology Data trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Human Gastrointestinal Physiology Data: 1 US clinical trial tracked, 1 recruiting.

Human Gastrointestinal Physiology Data is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 1 of these trials.

Enrollment posture brief

Registry condition human-gastrointestinal-physiology-data

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Human Gastrointestinal P (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Human Gastrointestinal Physiology Data

Human Gastrointestinal Physiology Data lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Human Gastrointestinal Physiology Data on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Human Gastrointestinal Physiology Data is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Human Gastrointestinal Physiology Data records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

13C6-Glipizide Drug
1 trials
Rifaximin 200Mg Tab Drug
1 trials
Glipizide ER 5 MG 24 HR Extended Release Oral Tablet Drug
1 trials
Glucotrol XL 5Mg Extended-Release Tablet Drug
1 trials

US sites by state

Facility locations filed on Human Gastrointestinal Physiology Data trials. A trial with sites in several states counts in each.

Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Human Gastrointestinal Physiology Data page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Human Gastrointestinal Physiology Data trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Michigan sponsors the most Human Gastrointestinal Physiology Data trials on record, review their full trial history before evaluating a specific study. See University of Michigan's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Human Gastrointestinal Physiology Data condition card totals 1 registered trials; most-linked intervention 13C6-Glipizide; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.